One rival to Imjudo/Imfinzi in previously untreated HCC is Roche's dual regimen of PD-L1 inhibitor Tecentriq (atezolizumab) and CD20-targeting antibody Avastin (bevacizumab), which was approved by ...

Also known as selective COX-2 inhibitors, these medications treat inflammatory pain. Selective COX-2 inhibitors are a type of nonsteroidal anti-inflammatory medication (also known as NSAIDs).

In addition, some antibodies bind to different epitopes of CD20, which may yield different ... are also of interest. The mTOR inhibitor temsirolimus is active in refractory MCL, with a 38% ...

ACE inhibitors are best known for treating high blood pressure. They work by targeting the hormone angiotensin II. Angiotensin-converting enzymes (ACE) inhibitors help blood vessels to relax and open.

BeiGene's BTK inhibitor Brukinsa (zanubrutinib ... for adult patients with MZL who have received at least one prior anti-CD20-based therapy within the next few weeks. The AI effect in pharma ...

The recently published article in Science by the Genentech team presents the structure of CD20 in complex with the therapeutic monoclonal antibody RTX. This study underscores the significance of ...

ImmunityBio has around $130.1 million in cash, enough to fund operations for at least the next 12 months. Read why I'm very ...

Researchers from Shanghai Institute of Biological Products Co. Ltd. published details on the development and preclinical characterization of novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 ...

Trial-in-progress presentation provides an overview of a Phase 2 study of sonrotoclax in patients with R/R WM, who have been previously treated with a BTK inhibitor therapy or anti-CD20–based ...

On account of these limitations, he typically favors the alkylating agent bendamustine plus the anti-CD20 rituximab over BTK inhibitors in the absence of MYD88 mutations. This once standard ...